Transcriptomic analysis reveals optimal cytokine combinations for SARS-CoV-2-specific T cell therapy products

Adoptive T cell immunotherapy has been used to restore immunity against multiple viral targets in immunocompromised patients after bone-marrow transplantation and has been proposed as a strategy for preventing coronavirus 2019 (COVID-19) in this population. Ideally, expanded severe acute respiratory...

Descripción completa

Detalles Bibliográficos
Autores principales: Durkee-Shock, Jessica, Lazarski, Christopher A., Jensen-Wachspress, Mariah A., Zhang, Anqing, Son, Aran, Kankate, Vaishnavi V., Field, Naomi E., Webber, Kathleen, Lang, Haili, Conway, Susan R., Hanley, Patrick J., Bollard, Catherine M., Keller, Michael D., Schwartz, Daniella M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050197/
https://www.ncbi.nlm.nih.gov/pubmed/35506060
http://dx.doi.org/10.1016/j.omtm.2022.04.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050197/
https://www.ncbi.nlm.nih.gov/pubmed/35506060
http://dx.doi.org/10.1016/j.omtm.2022.04.013

Ejemplares similares